Alyeska Investment Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100,000
| Closed | -$2.55M | – | 519 |
|
|
2022
Q4 | $2.55M | Buy |
+100,000
| New | +$2.55M | 0.03% | 304 |
|
|
2018
Q3 | – | Sell |
-338,789
| Closed | -$2.38M | – | 467 |
|
|
2018
Q2 | $2.38M | Buy |
338,789
+10,834
| +3% | +$76K | 0.02% | 319 |
|
|
2018
Q1 | $4.67M | Sell |
327,955
-2,955
| -0.9% | -$42.1K | 0.04% | 274 |
|
|
2017
Q4 | $2.9M | Hold |
330,910
| – | – | 0.02% | 279 |
|
|
2017
Q3 | $3.87M | Buy |
330,910
+5,910
| +2% | +$69.2K | 0.03% | 291 |
|
|
2017
Q2 | $4.54M | Buy |
325,000
+152,614
| +89% | +$2.13M | 0.04% | 274 |
|
|
2017
Q1 | $2.37M | Sell |
172,386
-52,614
| -23% | -$722K | 0.02% | 373 |
|
|
2016
Q4 | $1.61M | Buy |
225,000
+56,228
| +33% | +$403K | 0.01% | 392 |
|
|
2016
Q3 | $2.56M | Buy |
168,772
+43,772
| +35% | +$664K | 0.02% | 362 |
|
|
2016
Q2 | $1.23M | Sell |
125,000
-50,000
| -29% | -$492K | 0.01% | 373 |
|
|
2016
Q1 | $2.33M | Buy |
+175,000
| New | +$2.33M | 0.02% | 313 |
|